Raizenne, Brendan L.
Zheng, Xinyan
Mao, Jialin
Zorn, Kevin C.
Cho, Ahra
Elterman, Dean
Bhojani, Naeem
Sedrakyan, Art
Chughtai, Bilal https://orcid.org/0000-0002-0515-2578
Article History
Received: 22 July 2021
Accepted: 30 December 2021
First Online: 2 February 2022
Declarations
:
: NB is a consultant and investigator for Boston Scientific, Olympus, and PROCEPT BioRobotics. BC is a consultant and investigator for Boston Scientific, Olympus and Prodeon. KCZ is a consultant for Boston Scientific, and PROCEPT BioRobotics. DE is consultant and investigator for Boston Scientific, PROCEPT BioRobotics, Prodeon, Olympus, Urotronic, and Zenflow. All other authors report no relevant conflicts of interest.
: The data used to produce this publication was provided by the New York State Department of Health (NYSDOH). However, the conclusions derived, and views expressed therein are those of the author(s) and do not reflect the conclusions or views of NYSDOH. NYSDOH, its employees, officers, and agents make no representation, warranty or guarantee as to the accuracy, completeness, currency, or suitability of the information provided here.
: Not applicable.
: Not applicable.